Summary
Cryoport, Inc., a life sciences services company, provides temperature-controlled logistics solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers Cryoportal, a cloud-based logistics management platform that supports the management of shipments, which includes order entry, document preparation, customs documentation, courier management, real-time shipment tracking and monitoring, issue resolution, and regulatory compliance requirements; and CryoPort Express Shippers, which is used to ensure that the stability of shipped biologic commodities is maintained throughout the shipping cycle. It also provides information dashboards and validation documentation for shipments through data collected by the SmartPak Condition Monitoring System; and vacuum insulated aluminum dewars and cryogenic freezers systems. In addition, the company offers biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; transportation of frozen biological specimens to and from customer locations; and management of incoming and outgoing biological specimens, as well as provides logistics support and management; and short-term logistics and engineering consulting services. It serves biopharma/pharma, animal health, and human reproductive medicine markets. The company was founded in 1999 and is headquartered in Brentwood, Tennessee.
History
CryoPort was founded in California in 2000 by Noel J. Guillama and Mr. Robert S. Barton for the purpose of shipping biologic materials and facilitating the sample bank industry. In 2007 CryoPort began offering customized temperature-controlled logistics services to the rapidly growing regenerative medicine and biologic drug markets. The cryogenic shipping industry had been relatively untouched since the early 80's until CryoPort became the first to bring an alternative to the highly manual process.
Mission
CryoPort provides our customers with comprehensive, reliable, temperature-controlled logistics solutions; enabling them to excel in their respective markets.
Vision
CryoPort is committed to developing and delivering the most innovative, comprehensive temperature-controlled logistics solutions to our customers in the life sciences industry.
Key Team
Tony Ippolito (VP & Gen. Counsel)
Mr. Thomas J. Heinzen (VP of Corp. Devel.)
Mr. Raymond Takahashi M.D. (Exec. Officer)
Mr. Bret Bollinger (Chief Technology Officer of Cryoport Systems, LLC)
Mr. David Petreccia M.D. (Exec. Officer)
Mr. Phil Wilson (Chief Operating Officer of Cryoport Systems, LLC)
Recognition and Awards
American Business Awards, Gold Stevie 2018; Frost & Sullivan, 2017 Life Sciences Cold Chain Logistics Company of the Year; TICE Award 2017; Multichannel Merchant Awards 2017; DTTL Global Innovation Award 2018; Supply & Demand Chain Executive Magazine's 2018 Provider Pro to Know
References
United States 